Top 5 Pharma Industry News Articles That Stole Christmas

“And the Grinch, with his Grinch-feet ice cold in the snow, stood puzzling and puzzling, how could it be so? It came without ribbons. It came without tags. It came without packages, boxes or bags. And he puzzled and puzzled ’till his puzzler was sore. Then the Grinch thought of something he hadn’t before. What if Christmas, he thought, doesn’t come from a store? What if Christmas, perhaps, means a little bit more?”

Christmas is almost here and it seems all publications went quiet, to a short stop before being back to blizzard. This week’s compile is about end of year news covering glorious outlooks for data analysts, Hepatitis C treatment war and some insights on Google searches and healthcare.

Warmest thoughts and best wishes for a wonderful Holiday and a Happy New Year!

1. Drug Price War Takes Pharma Back To The Future

By Matthew Herper, published on Forbes

For biotech investors, the news that AbbVie has cut a deal with Express Scripts to sell its new hepatitis C treatment, the Viekira Pak, at a significant and undisclosed discount seems nothing short of disaster. It means that Gilead Pharmaceuticals will have to compete on price, not just efficacy with its $84,000-per course Sovaldi and $95,000 Harvoni. Read more to discover the influence of me too drugs on the market and how price competition impacts bottom line.

Read More

2. The Big Data of Wearables

By Rohit Yadav, published on KD Nuggets

According to IDC, “wearables took a huge step forward over the past year and shipment volumes will exceed 19 million units in 2014, more than tripling last year’s sales. From there, the global market will swell to 111.9 million units in 2018.” Yadav takes a look at 4 major ways wearables can improve life.

Read More

3. Tunnah’s musings: Reviewing the Health of 2014 on Google

By Paul Tunnah, published on Pharma Phorum

As 2014 comes to a close, Paul Tunnah takes an interesting look at what made “top of Google” in the past 12 months and seeks inspiration as to what these searches can teach us about the direction of healthcare in 2015. With Ebola and ALS in the top 10 – what can be learned from Robin Williams’ passing away and what has Dr.Google in store for the year to come.

Read More

4. Data Mining Tops LinkedIn’s List of the ‘Hottest Skills of 2014’

By Todd Wasserman, published on Mashable

Whether its Moneyball, President Obama’s election campaigns or just the social media-led explosion of information, “statistical analysis and data mining” topped LinkedIn’s list of the 25 Hottest Skills That Got People Hired in 2014. For those who have those skills, these are good times. Glassdoor reports that the average salary for a data scientist is $118,709 versus $64,537 for a programmer. A McKinsey study predicts that by 2018, the U.S. could face a shortage of 140,000 to 190,000 “people with deep analytic skills” as well as 1.5 million “managers and analysts with the know-how to use the analysis of big data to make effective decisions.” Read on to dicover the 25 Hottest Skills of 2014 on LinkedIn.

Read More

5. The 4 Knows of a Drug Launch Officer

By Annie Reiss, published on Verix Blog

The changing health care landscape requires innovative, data-driven approaches to drug launches. The one-size-fits all approach to launching a blockbuster drug every other year is now giving way to smaller, more frequent tailored launches of pipeline drugs. With more launches, creating a chief launch officer with a dedicated team is essential. Discover the role of the drug launch officers and the 4 knows to becoming successful at launching your new drug.

Read More


The Grinch – How the Grinch Stole Christmas, JPEG Image, Fanpop, accessed 24 December 2014, <>